Alternative investigations for irritable bowel syndrome

  title={Alternative investigations for irritable bowel syndrome},
  author={Hamish Philpott and Sanjay Nandurkar and John S. Lubel and Peter R. Gibson},
  journal={Journal of Gastroenterology and Hepatology},
Alternative and complementary medical practitioners have long advocated alternative treatments for irritable bowel syndrome. A more recent development has been the use of alternative investigations by these practitioners and, in the era of internet advertising, directly by patients themselves. The aim of the present study was to examine the alternative investigations that are advocated for the assessment of gastrointestinal disease and that are available through mainstream laboratories in… 

Is national socioeconomic status related to prevalence of irritable bowel syndrome?

This study investigates the possible relation between human development and prevalence of IBS, at national level, and the influence of socioeconomic status on prevalence ofIBS.

Allergy tests do not predict food triggers in adult patients with eosinophilic oesophagitis. A comprehensive prospective study using five modalities

The use of allergy tests to guide dietary treatment for eosinophilic oesophagitis (EoE) is controversial and data are limited. Aeroallergen sensitisation patterns and food triggers have been defined

Functional bowel symptoms and diet

Dietary manipulation is now a key management strategy in patients with functional bowel symptoms and the low FODMAP diet is now the primary dietary therapy for such patients.

Food allergy in irritable bowel syndrome: The case of non-celiac wheat sensitivity.

Pending further scientific evidence, a cautious approach is advisable but the concept of food allergy should be included as a possible cause of IBS, and a dietary approach may have a place in the routine clinical management of Ibs.

Proteomics and irritable bowel syndrome

This review aims to present an overview of implementation of proteomics in experimental studies in the field of IBS and finds that despite the intensive research performed in this field, an appropriate biomarker is not yet available.

Adverse Food Reaction and Functional Gastrointestinal Disorders: Role of the Dietetic Approach.

The aim of this review is to provide to the general physician, according to the available evidence, the most appropriate diagnostic work-ups for recognizing the different clinical scenarios (i.e. food allergy and intolerance, functional bowel diseases, gluten-related syndromes), to identify their clinical interrelationships and to suggest the mostappropriate management.

Review article: the aetiology, diagnosis, mechanisms and clinical evidence for food intolerance

  • M. Lomer
  • Medicine, Biology
    Alimentary pharmacology & therapeutics
  • 2015
Food intolerance is non‐immunological and isoften associated with gastrointestinal symptoms and is often associated with vomiting and diarrhoea.

Alterations in fecal short-chain fatty acids in patients with irritable bowel syndrome

A meta-analysis of case-control studies, randomized controlled trials, and self-controlled studies revealed differences between patients with IBS and HCs in terms of fecal SCFAs, and found that restricted diets correlated with fecal butyrate reduction in IBS, suggesting propionate andbutyrate could be used as biomarkers for IBS diagnosis.

The role of food and aeroallergens in eosinophilic oesophagitis

The need both to better understand the role of food and aeroallergens (with more comprehensive prospective studies), and to offer less invasive and thereby safer endoscopic surveillance is readily apparent.

IgG and EoE: too soon for a paradigm shift away from IgE.

Serum IgG4 antibodies to common food antigens were detectable in disease-free controls as well as those with EoE, although were elevated to a greater degree in the latter group.



Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia

The drivers of conventional and, especially, alternative health care use for irritable bowel syndrome and functional dyspepsia are not clear and the need for further study is unclear.

Intestinal permeability and irritable bowel syndrome

  • M. CamilleriH. Gorman
  • Medicine
    Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society
  • 2007
While a subgroup of patients with IBS appears to have evidence of increased intestinal permeability, improvements in the methods and validation are key to further research in this field in order to better understand intestinal barrier functions in IBS.

Inflammation and microflora.

Rifaximin therapy for patients with irritable bowel syndrome without constipation.

Among patients who had IBS without constipation, treatment with rifaximin for 2 weeks provided significant relief of IBS symptoms, bloating, abdominal pain, and loose or watery stools.

Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials.

Searching PubMed, EMBASE, Scopus, Web of Science and Cochrane Central Register of Controlled Trials were searched from 1996 to September 2007. Search terms were reported. Additional studies were

Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario

Post‐infectious irritable bowel syndrome is a common clinical phenomenon of uncertain aetiology that requires further investigation to determine its cause.

Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial

Food elimination based on IgG antibodies may be effective in reducing IBS symptoms and is worthy of further biomedical research.

A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome

Probiotics may have a role in alleviating some of the symptoms of IBS, a condition for which currently evidence of efficacy of drug therapies is weak, however, as IBS is a condition that is chronic and usually intermittent longer term trials are recommended.

Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome

This study hypothesized in this study that altered GI microbiota contribute to IBS symptoms through increased levels of organic acids.

[A meta-analysis of probiotics for the treatment of irritable bowel syndrome].

Probiotics have beneficial effects on IBS, which can improve the patients' symptoms and with less adverse reaction, and standardize its usage, dosage and course of treatment.